This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The sessions this year range from business sessions, including topics on product placement, advocacy, and inventory management, to educational sessions, including diabetes, immunizations, and hormonal contraceptive services. The Drug Topics team will be onsite at the meeting providing coverage of all the most important happenings.
She highlighted the challenges of maintaining accurate, transparent vaccine guidance, focusing on the importance of trusted health care providers helping patients understand immunization strategies. Pharmacists and pharmacies play a very important role in keeping their communities healthy with services such as immunizations.
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) were safe and effective as adjunctive therapies for patients with type 1 diabetes (T1D) and overweight or obesity, according to an abstract presented at the American Diabetes Association 85th Scientific Sessions, held in Chicago, Illinois, from June 20-23, 2025.
Research presented at DDW 2024 found there was no significant association between immune response and hepatitis B vaccine types in patients with Hepatitis C.
READ MORE: Immunization Resource Center Ready to impress your pharmacy colleagues with the latest drug information, industry trends, and patient care tips? Focus on educating the public and letting the patient, our patients, know the value of vaccines, and hopefully we can continue to keep our patients healthy.
Posters presented at the APhA 2024 Annual Meeting and Exposition discussed pharmacist barriers in pediatric immunizations, a novel meningococcal vaccine, and the need for inpatient reviews of vaccination history.
The Immunization Action Coalition also has a travel vaccine section on its website with many resources. Depending on the pharmacy practice act for your state, you may or may not be able to provide all vaccinations recommended by the Advisory Committee on Immunization Practices. The Immunization Action Coalition. REFERENCES 1.
A smart insulin pen cap system that integrates with continuous glucose monitors (CGM) to provide alerts in real time showed sustained glycemic improvement and reduced diabetes distress through 12 months, according to data presented at the American Diabetes Association’s 85th Scientific Sessions, which were held June 20-23 in Chicago, Illinois.
The data from POETYK PsA-1 is being presented at the European Alliance of Associations for Rheumatology Congress, being held in Barcelona, Spain, from June 11 to 14. Additionally, a significantly greater proportion of patients who received the therapy did not have radiographic progression. References 1.
With federal reform continuously being punted along on Capitol Hill, state reform in places like Arkansas and Iowa may present hope for community pharmacies and patients with poor access to medications. “If
link] Recent Videos Related Content Pharmacist Outreach Reduces Therapeutic Inertia in T2D | ADA 2025 Killian Meara June 23rd 2025 Article Data presented at ADA’s 85th Scientific Sessions showed patients who received physician education with clinical pharmacist outreach had significantly better A1c levels at 6 months compared to usual care.
1 “In line with the goals of its Immunization Agenda 2030, WHO has identified a new list of 17 high-priority global endemic pathogens for vaccine research and development, of which skin pathogens account for at least 8, reinforcing the need for continued focus in this area.” Vaccines in dermatology-present and future: a review.
In a session at the Pharmacy Quality Alliance Annual Meeting 2025, presenters stated that approximately 68% of patients have at least 1 unmet SDOH. Community pharmacies, which are very accessible to the public, are well positioned to address social determinants of health (SDOH), including food insecurity.
1 “Psoriasis is a chronic disease in which the immune system becomes overactive, causing skin cells to multiply too quickly,” wrote the National Institute of Arthritis and Musculoskeletal and Skin Diseases. Significantly linked with psoriasis, PsA is a chronic skin and nail disease 3 that impacts up to 30% of patients with psoriasis.
The Opportunities, Gaps in Diabetes Care Making Pharmacists Stand Out | ADA 2025 Brian Nowosielski ; Jon Easter, RPh July 4th 2025 Podcast Following his presentation at the American Diabetes Association’s 85th Scientific Sessions, Jon Easter caught up with Drug Topics to discuss the pharmacists’ role in diabetes management.
Despite a high prevalence of childhood and youth-aged obesity, the use of medications for treating obesity is persistently low among children and young adults (YA), according to an abstract presented at the American Diabetes Association’s 85th Scientific Sessions, held in Chicago, Illinois, from June 20-23, 2025. References 1.
The evidence presented to the WHO team pointed to what’s sometimes called an immunity gap that was created by the pandemic. But a rapidly organized meeting Thursday between the World Health Organization and health officials in China assuaged much of that concern.
New research published Thursday in Science has identified proteins present in the blood of people with long Covid that could point the way to a much-needed diagnostic test and possibly to future therapeutic targets.
Recognising the potential of CAR T cells to act as highly targeted therapeutics, several biotechnology companies – including Sangamo Therapeutics – have established development pipelines of CAR T regulatory cells (Tregs) that aim to tackle immune?mediated What are Tregs and how are they applicable to immune-mediated disease?
Investigators assessed whether administering a temperature-stable vaccine containing both ID93 and GLA-SE in a single vial would be as effective at inducing an immune response as a regimen in which non-thermostable ID93 and liquid GLA-SE are held in two vials and combined prior to injection. However, Sagawa et al.
The company’s myvac platform creates individualized immunotherapies that stimulate and “educate” a patient’s immune system to destroy cancer tumors. Unlike other approaches, it is tailor-made for each patient, based on the mutations specific to their tumor,” Steiner said. “We
Instead, the study tested for an immune response at levels that are thought to protect against the disease if infected with the virus. The post Chikungunya vaccine demonstrates 99 percent immune response appeared first on European Pharmaceutical Review. Results from the Phase III clinical trial was published in The Lancet.
By acting on hair follicle stem cells—which remain present even in balding areas—PP405 offers a promising option for people often left out by existing therapies. PP405 takes a different approach from current hair loss treatments, which mostly focus on secondary causes like hormones.
While still preliminary, the experience with the two patients back up Talaris’ hope that giving a one-shot dose of FCR001 the day after an organ transplant could stimulate immune tolerance in the recipient, and avoid the side effects of current drug treatments such as infections, heart disease, and some forms of cancer.
With the social media boom in recent decades and a massive flow of health care information, ensuring all online skin care interventions are safe and effective may present challenges for regulators and providers. In health sciences, a standardized tool is needed to assess the quality of social media digital interventions.”
At a meeting Thursday of the Advisory Committee on Immunization Practices, vaccine safety experts from the two agencies presented data that showed what appears to be an elevated rate of GBS, as the condition is called, among people who got the Pfizer vaccine, although there were also cases detected among people who got the GSK product.
New presentation offers health care providers with a more convenient, ready-to-use immunization option for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W.
But as researchers from different companies and academic institutions presented promising early data at the American Association for Cancer Research annual meeting in San Diego this week, experts said there’s a collective feeling of turning a corner. SAN DIEGO — Cancer vaccines have traveled a potholed road over the last decade.
NEW ORLEANS — Researchers had hoped in recent years that a protein called GPRC5D might offer a new way to get the immune system to hunt down and destroy multiple myeloma cells. Now, the results of a Phase 2 study on a bispecific antibody targeting this protein offers confirmation.
The vaccine effectiveness estimates, which showed unusually robust protection of children against influenza B viruses but more modest protection of people aged 65 and older against influenza A viruses, were presented Wednesday at a meeting of the CDC’s expert vaccine panel, the Advisory Committee on Immunization Practices.
A study has identified subtle changes in how immune cells respond to different severe febrile illnesses in children, which could lead to improved treatments. In the clinic currently, our treatments for dysfunctional immunity are poor and not targeted to individual children.
Prior to October 2024, the Advisory Committee on Immunization Practices (ACIP) recommended use of a PCV only for all adults aged 65 years and older, including those aged 19 to 64 years with risk conditions for pneumococcal disease. 1,2 A particular disease burden is present for Black Americans. Kobayashi M, Leidner AJ, Gierke R, et al.
The spray is based on the SporeVax technology developed at Sporegen by Royal Holloway University Professor Simon Cutting and takes the form of heat killed spores of a bacterium – Bacillus subtilis – that stimulate a part of the innate immune system known as mucosal immunity.
Merck presented results from the STRIDE-10 phase 3 trial at the 34th European Society of Clinical Microbiology and Infectious Diseases in Barcelona, Spain.
CanSinoBIO’s inhalant has finished phase three trials in China and is presently undergoing trials in several countries. It then elicits an immune response against that spike protein. When you have mucosal immunity, the immunoglobulins called IgAs start neutralising the virus at the point of entry. The inhalant version.
Before TIL infusion, the patient undergoes lymphodepletion, which reduces the proportion of myeloid immune suppressive cells and creates space for the incoming lymphocytes. The high level of neoantigens in melanoma makes this the ideal setting for TIL therapy, with tumours often containing multiple clones of tumour-reactive immune cells.
The needle-free vaccine can also elicit complete immune protection against the SARS-CoV-2 virus after just a single inhalation. According to studies, Convidecia Air could prompt robust cellular, humoral and mucosal immunity to attain triple protection as well as control the virus spread and the infection.
Results of a Phase I/II study has revealed that a booster dose of a novel, self-amplifying messenger RNA (sa-mRNA) COVID-19 vaccine induces a robust, broadly cross-reactive, and durable immune response in adults. All three vaccines induced robust neutralising immune response against the D614G variant at Day 29.
It also probably marks the end of the road for crenezumab, which Roche’s Genentech subsidiary licensed from AC Immune in 2006 in a deal initially valued at $300 million. Before the end of the year, Roche should report results from two phase 3 studies in early-stage patients.
aVaxziPen, a biotech company focusing on the development of a novel needle-free vaccine delivery platform, has announced that it will present data at the World Vaccine Congress (WVC) in Washington, US. read more
Once within the tumour, it stimulates receptors on immune cells to mount an attack on the cancer. At the American Society of Haematology (ASH) meeting last December, the biotech presented data showing that the drug could halt the growth of tumours, with the effects lasting beyond the treatment phase.
Moderna’s next-generation COVID-19 vaccine mRNA-1283 demonstrated a higher immune response against SARS-CoV-2, interim results from the company’s Phase III trial show. These findings were based on data comparing the treatment to mRNA-1273.222 (Spikevax ® ), Moderna’s licensed vaccine for the condition.
Certain RNA methyltransferases regulate RNA sensing and innate immune activation and represent novel immune-regulatory targets. We anticipate presenting results from our Phase I study in 2023.” In addition, STC-15 has shown efficacy in leukaemia models via mechanisms including inhibition of leukaemia stem cell function.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content